Theravance Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Theravance Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Theravance Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 48.9M shares, a 8.89% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 48.9M -4.77M -8.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 48.6M -12M -19.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 48.1M -17.1M -26.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 50.8M -16.5M -24.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 53.7M -22.7M -29.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 60.5M -15.5M -20.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 65.2M -9.21M -12.4% Dec 31, 2022 10-K 2024-03-01
Q3 2022 67.4M -6.33M -8.59% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 76.4M +2.96M +4.03% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 76.1M +10.9M +16.7% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 74.4M +10.1M +15.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 73.7M +9.74M +15.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 73.5M +9.96M +15.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 65.2M +2.21M +3.51% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 64.3M +7.31M +12.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 64M +7.19M +12.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 63.5M +6.88M +12.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 63M +6.88M +12.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 57M +1.33M +2.4% Dec 31, 2019 10-K 2021-02-26
Q3 2019 56.8M +1.35M +2.44% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 56.6M +1.53M +2.78% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 56.1M +1.32M +2.42% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 55.7M +1.3M +2.39% Dec 31, 2018 10-K 2020-02-27
Q3 2018 55.4M +1.32M +2.45% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 55.1M +1.28M +2.37% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 54.8M +1.51M +2.83% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 54.4M +1.55M +2.93% Dec 31, 2017 10-K 2019-02-28
Q3 2017 54.1M +6M +12.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 53.8M +5.98M +12.5% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 53.3M +11.8M +28.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 52.8M +14.9M +39.1% Dec 31, 2016 10-K 2018-02-28
Q3 2016 48.1M +14.2M +41.7% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 47.9M +13.9M +41% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 41.5M +7.65M +22.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 38M +5.76M +17.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 33.9M +1.71M +5.3% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 33.9M +1.68M +5.21% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 33.8M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 32.2M +32.2M Dec 31, 2014 10-K 2016-03-11
Q3 2014 32.2M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 32.3M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 0 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.